The stent, called the Evolution Duodenal Controlled-Release Stent, will be available to use to combat gastric outlet obstruction as a result of advanced GI cancers. A European study found that 21 of 23 patients had “significant improvement” with the stent.
Related Articles about FDA Device Approvals:
GE’s New MRI Machine Gets FDA Approval
FDA Forms Expert Panel to Speed up Device Approval
FDA Continuing Work to Improve Sound Development of Medical Products
